BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tran HM, Wu KS, Sung SY, Changou CA, Hsieh TH, Liu YR, Liu YL, Tsai ML, Lee HL, Hsieh KL, Huang WC, Liang ML, Chen HH, Lee YY, Lin SC, Ho DM, Chang FC, Chao ME, Chen W, Chu SS, Yu AL, Yen Y, Chang CC, Wong TT. Upregulation of Protein Synthesis and Proteasome Degradation Confers Sensitivity to Proteasome Inhibitor Bortezomib in Myc-Atypical Teratoid/Rhabdoid Tumors. Cancers (Basel) 2020;12:E752. [PMID: 32235770 DOI: 10.3390/cancers12030752] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Calandrini C, van Hooff SR, Paassen I, Ayyildiz D, Derakhshan S, Dolman MEM, Langenberg KPS, van de Ven M, de Heus C, Liv N, Kool M, de Krijger RR, Tytgat GAM, van den Heuvel-Eibrink MM, Molenaar JJ, Drost J. Organoid-based drug screening reveals neddylation as therapeutic target for malignant rhabdoid tumors. Cell Rep 2021;36:109568. [PMID: 34433038 DOI: 10.1016/j.celrep.2021.109568] [Reference Citation Analysis]